{"nct_id":"NCT05791097","title":"Study of Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Platinum-based Doublet Chemotherapy as First-line Treatment for Participants With Locally Advanced or Metastatic NSCLC.","status":"WITHDRAWN","status_verified_date":"2023-07","start_date":"2023-07-28","start_date_type":"ESTIMATED","primary_completion_date":"2027-12-24","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12-26","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}